THERAPY WITH CERTOLIZUMAB PEGOL AND OTHER TNF-A INHIBITORS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM THE CORRONA REGISTRY

被引：0
|
作者：
Pappas, D. A.
Etzel, C. J. [1 ]
Bedenbaugh, A. [2 ]
Tambiah, J. [3 ]
Greenberg, J. D. [4 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] UCB Pharma, Smyrna, GA USA
[3] UCB, Smyrna, GA USA
[4] NYU, Sch Med, New York, NY USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.256
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS11
引用
收藏
页码：A43 / A43
页数：1
相关论文
共 50 条
  • [11] Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
    Dimitrios A. Pappas
    Taylor Blachley
    Steve Zlotnick
    Jennie Best
    Kelechi Emeanuru
    Joel M. Kremer
    Rheumatology and Therapy, 2020, 7 : 357 - 369
  • [12] METHOTREXATE DISCONTINUATION AND DOSE DECREASES AFTER THERAPY WITH TOCILIZUMAB: RESULTS FROM THE CORRONA RHEUMATOID ARTHRITIS REGISTRY
    Pappas, Dimitrios A.
    Blachley, Taylor
    Zlotnick, Steve
    Best, Jennie H.
    Emeanuru, Kelechi
    Kremer, Joel
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1150 - 1150
  • [13] Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
    Pappas, Dimitrios A.
    Blachley, Taylor
    Zlotnick, Steve
    Best, Jennie
    Emeanuru, Kelechi
    Kremer, Joel M.
    RHEUMATOLOGY AND THERAPY, 2020, 7 (02) : 357 - 369
  • [14] Methotrexate Discontinuation and Dose Decreases After Therapy with Tocilizumab: Results from the Corrona Rheumatoid Arthritis Registry
    Pappas, Dimitrios
    Blachley, Taylor
    Zlotnick, Steve
    Best, Jennie
    Emeanuru, Kelechi
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [15] One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry
    Leslie R. Harrold
    Heather J. Litman
    Katherine C. Saunders
    Kimberly J. Dandreo
    Bernice Gershenson
    Jeffrey D. Greenberg
    Robert Low
    Jeffrey Stark
    Robert Suruki
    Srihari Jaganathan
    Joel M. Kremer
    Mohamed Yassine
    Arthritis Research & Therapy, 20
  • [16] CLINICAL EFFICACY OF CERTOLIZUMAB PEGOL THERAPY IN PATIENTS WITH JAPANESE ACTIVE RHEUMATOID ARTHRITIS 52 WEEK RESULT ∼A MULTICENTER REGISTRY STUDY∼
    Kanayama, Y.
    Kaneko, A.
    Takahashi, N.
    Kato, T.
    Hirano, Y.
    Hattori, Y.
    Asai, N.
    Ishiguro, N.
    Kojima, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1015 - 1016
  • [17] NEED TO ADVANCE THERAPY IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TRIPLE NBDMARD VS BIOLOGIC COMBINATION THERAPY: RESULTS FROM THE CORRONA REGISTRY
    Pappas, D. A.
    Karki, C.
    Litman, H.
    Greenberg, J. D.
    Kremer, J. M.
    Garg, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 249 - 249
  • [18] PERSISTENCE OF TOCILIZUMAB THERAPY AMONG PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE US-BASED CORRONA RHEUMATOID ARTHRITIS REGISTRY
    Pappas, D. A.
    Blachley, T.
    Best, J. H.
    Zlotnick, S.
    Emeanuru, K.
    Kremer, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 627 - 628
  • [19] Persistence of Tocilizumab Therapy Among Patients with Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
    Pappas, Dimitrios
    Blachley, Taylor
    Best, Jennie
    Zlotnick, Steve
    Emeanuru, Kelechi
    Kremer, Joel
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [20] Discontinuation of Biologic Therapy in Rheumatoid Arthritis: Analysis from the Corrona RA Registry
    Strand, Vibeke
    Miller, Paul
    Williams, Setareh A.
    Saunders, Katherine
    Grant, Shannon
    Kremer, Joel
    RHEUMATOLOGY AND THERAPY, 2017, 4 (02) : 489 - 502
12345